Danaher Corporation (BMV:DHR)

Market Cap	2.82T
Revenue (ttm)	445.44B
Net Income (ttm)	64.30B
Shares Out	n/a
EPS (ttm)	89.33
PE Ratio	43.92
Forward PE	26.42
Dividend	23.88 (0.60%)
Ex-Dividend Date	Sep 26, 2025

Volume	19
Average Volume	57
Open	3,960.00
Previous Close	3,982.35
Day's Range	3,960.00 - 3,960.00
52-Week Range	3,358.00 - 5,105.00
Beta	0.80
RSI	54.52
Earnings Date	Jan 28, 2026

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1969
• Employees: 63,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: DHR

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.

Financial numbers in USD